Mazzon and colleagues also reported that intraperitoneal injection of the adenosine A2AR agonist, CGS21680, resulted in relief of arthritis symptoms in CIA mice and a decrease in release of TNF-α and IL-1β, pointing to a role of A2AR in CIA [14]. This evidence concerns the gene TNF and arthritic joint disease.